These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 2356667

  • 1. [Individual dosage schedule of heparin therapy in chronic hemodialysis by analytic studies of blood coagulation].
    Gläser V, Anstadt M.
    Z Urol Nephrol; 1990 Mar; 83(3):133-40. PubMed ID: 2356667
    [Abstract] [Full Text] [Related]

  • 2. [Measurement of activated whole blood coagulation as a control parameter for heparin dosage in hemodialysis].
    Kraatz G, Lopot F.
    Z Urol Nephrol; 1984 Aug; 77(8):465-71. PubMed ID: 6495895
    [Abstract] [Full Text] [Related]

  • 3. [Heparin dosage in chronic hemodialysis (author's transl)].
    Vogel GE, Hansen W, Goldmann FL, Kopp KF.
    Med Klin; 1977 Oct 07; 72(40):1617-23. PubMed ID: 916946
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacodynamics of unfractionated heparin during and after a hemodialysis session.
    Brunet P, Simon N, Opris A, Faure V, Lorec-Penet AM, Portugal H, Dussol B, Berland Y.
    Am J Kidney Dis; 2008 May 07; 51(5):789-95. PubMed ID: 18436089
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of a sliding scale protocol for heparin on the ability to maintain whole blood activated partial thromboplastin times within a desired range in hemodialysis patients.
    Low CL, Bailie G, Morgan S, Eisele G.
    Clin Nephrol; 1996 Feb 07; 45(2):120-4. PubMed ID: 8846524
    [Abstract] [Full Text] [Related]

  • 8. Heparin elimination and hemostasis in hemodialysis.
    Wilhelmsson S, Lins LE.
    Clin Nephrol; 1984 Dec 07; 22(6):303-6. PubMed ID: 6525772
    [Abstract] [Full Text] [Related]

  • 9. [Use of activated coagulation time for evaluation of the degree of heparinization and calculation of heparin pharmacokinetic parameters during hemodialysis].
    Khodas MIa, Piatnitskaia GKh, Lanskaia IM, Maksimenko VA, Savina ME.
    Urol Nefrol (Mosk); 1988 Dec 07; (3):42-8. PubMed ID: 3218006
    [No Abstract] [Full Text] [Related]

  • 10. Hemodialysis without heparin infusion using Cordis Dow 3500 hollow fiber.
    Raja R, Kramer M, Rosenbaum JL, Bolisay C, Krug M.
    Proc Clin Dial Transplant Forum; 1980 Dec 07; 10():39-42. PubMed ID: 7346852
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The impact of heparin bolus from dysfunctional lumen of dual lumen central venous catheter on activated partial thromboplastin time during hemodialysis: is additional heparinization necessary?].
    Sefer S, Kes P, Raić B, Heinrich B, Degoricija V, Szavits-Nossan J.
    Acta Med Croatica; 2006 Jun 07; 60(3):281-5. PubMed ID: 16933844
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Activation of coagulation during hemodialysis: effect of blood lines alone and whole extracorporeal circuit.
    Lucchi L, Ligabue G, Marietta M, Delnevo A, Malagoli M, Perrone S, Stipo L, Grandi F, Albertazzi A.
    Artif Organs; 2006 Feb 07; 30(2):106-10. PubMed ID: 16433843
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patient.
    Nowak G, Bucha E, Brauns I, Czerwinski R.
    Wien Klin Wochenschr; 1997 May 23; 109(10):354-8. PubMed ID: 9200807
    [Abstract] [Full Text] [Related]

  • 18. Objective assessment of heparin requirements for hemodialysis in humans.
    Ireland H, Lane DA, Curtis JR.
    J Lab Clin Med; 1984 Apr 23; 103(4):643-52. PubMed ID: 6230409
    [Abstract] [Full Text] [Related]

  • 19. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
    Lavaud S, Canivet E, Wuillai A, Maheut H, Randoux C, Bonnet JM, Renaux JL, Chanard J.
    Nephrol Dial Transplant; 2003 Oct 23; 18(10):2097-104. PubMed ID: 13679486
    [Abstract] [Full Text] [Related]

  • 20. [Control of the heparin induced bleeding risk in haemodialysis patients (author's transl)].
    Vogel GE, Kopp KF.
    Med Klin; 1976 Jan 16; 71(3):116-9. PubMed ID: 1250190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.